Hyaluronan is a long, chain-like sugar molecule found in virtually every tissue in your body, with especially high concentrations in skin, joint fluid, and eyes. Often called hyaluronic acid or simply HA, it acts as a structural scaffold, a lubricant, a water-holding sponge, and a signaling molecule all at once. What makes it genuinely fascinating is that this single substance can do opposite things depending on its size: large intact chains tend to calm inflammation and protect tissues, while small fragments of the same molecule can sound biological alarms and ramp up immune activity. That dual nature has made hyaluronan one of the most studied molecules in fields ranging from dermatology to cancer biology.
What Hyaluronan Actually Is
At its core, hyaluronan is a glycosaminoglycan, a type of long-chain sugar built from a repeating two-part unit of glucuronic acid and N-acetylglucosamine. Unlike most similar molecules in the body, it carries no sulfate groups and is not attached to a protein backbone. Instead, it floats freely in the spaces between cells or sits on cell surfaces, where it can reach enormous lengths. A single hyaluronan chain in healthy tissue can contain thousands of sugar units and weigh over a million daltons, making it one of the largest molecules your body produces.
That size matters more than you might expect. Hyaluronan’s physical bulk lets it trap huge quantities of water, which is why tissues rich in it tend to be hydrated, cushioned, and gel-like. Joint fluid, the vitreous humor of the eye, and the gel layer surrounding an egg cell during ovulation all owe much of their consistency to hyaluronan’s water-binding capacity.
Why Size Changes Everything
One of the more counterintuitive things about hyaluronan is that the same basic molecule can either protect tissue or damage it, depending on the length of the chain. In its native, high-molecular-weight form (generally above about 1,000 kDa), hyaluronan is anti-inflammatory and tends to resist the growth of new blood vessels into tissue where they don’t belong. It suppresses immune activation and helps maintain the integrity of the spaces between your cells.
When disease, injury, or oxidative stress breaks those long chains into smaller fragments, the picture flips. Low-molecular-weight hyaluronan fragments act as danger signals. They bind to receptors on immune cells and trigger the release of inflammatory molecules. In lung injury, for instance, accumulating hyaluronan fragments function as endogenous danger signals that drive inflammation and draw immune cells into the tissue.
This isn’t a clean binary, though. Research on brain cells showed that both large and small hyaluronan influence inflammatory signaling pathways, but their effects aren’t simply “anti-inflammatory for big, pro-inflammatory for small.” The reality involves complex and sometimes overlapping effects on different signaling routes.
How Your Body Makes and Destroys It
Your cells produce hyaluronan using enzymes called hyaluronan synthases, or HAS enzymes, which sit in the cell membrane. Unlike most complex sugars that are assembled inside the cell and then shipped out in vesicles, hyaluronan is built and extruded through the membrane simultaneously. The enzyme grabs sugar building blocks from the inside of the cell, adds them to the growing chain, and pushes the chain outward through the membrane as it elongates. This process has been demonstrated in purified enzyme systems, where the enzyme alone is both necessary and sufficient to synthesize hyaluronan and push it across a membrane barrier.
Destruction is handled by two main pathways. Dedicated enzymes called hyaluronidases chop the chains into progressively smaller pieces. But reactive oxygen species, the free radicals generated during inflammation and normal metabolism, also break hyaluronan apart. In conditions like osteoarthritis, both pathways contribute to the loss of hyaluronan from joint fluid, which in turn degrades the fluid’s ability to cushion and lubricate the joint.
Receptors and How Cells Sense Hyaluronan
Hyaluronan doesn’t just fill space. Cells actively listen to it through surface receptors, the two most important being CD44 and RHAMM. CD44 is the primary receptor and is found on a wide range of cell types. When hyaluronan binds CD44, it can trigger cascades that affect cell movement, division, survival, and immune behavior.
RHAMM is less widely expressed but plays a critical backup role. In experiments with mice engineered to lack CD44, RHAMM stepped in during inflammation to bind hyaluronan, support cell migration, and even worsen inflammatory arthritis. In injured lung tissue, blocking RHAMM reduced macrophage accumulation by about 40% and improved tissue architecture, which tells you how much this receptor matters for directing immune cell traffic during injury.
The relationship between hyaluronan and its receptors is especially relevant in cancer, where tumors often hijack this system. Hyaluronan-receptor interactions can activate signaling pathways that promote tumor cell survival, movement, and resistance to treatment. In digestive cancers specifically, hyaluronan fragments interacting with tumor cells can promote proliferation, invasion, and even resistance to chemotherapy and radiation.
Where Hyaluronan Works in the Body
Joints
Synovial fluid, the slippery liquid inside your joints, depends heavily on hyaluronan for its lubricating and shock-absorbing properties. High-molecular-weight hyaluronan reduces friction between cartilage surfaces, and this effect improves with both concentration and chain length. Experiments on equine cartilage demonstrated that adding high-molecular-weight hyaluronan to injured joint fluid restored friction levels nearly to those seen in healthy fluid. Hyaluronan also works in concert with another lubricant called PRG4, and the two together provide better boundary lubrication than either alone.
Skin
Your skin is the single largest reservoir of hyaluronan in the body. It fills the extracellular matrix of both the outer epidermis and the deeper dermis, where it maintains hydration, elasticity, and firmness. Aging changes this picture dramatically. The most striking shift in aging skin is the near-disappearance of hyaluronan from the epidermis, even though it remains present in the dermis below. What remains in the dermis becomes increasingly locked into tissue structures and harder to extract. The combined result is the dryness, thinning, and loss of bounce that characterize older skin.
Wound Healing and Reproduction
Hyaluronan is considered one of the key players in tissue regeneration. It modulates inflammation, guides migrating cells to wound sites, and promotes the growth of new blood vessels, all of which are essential phases of healing. In reproduction, hyaluronan is critical to ovulation. The cells surrounding the egg rapidly produce a hyaluronan-rich gel that expands the cumulus-oocyte complex, a step necessary for the egg to be released and fertilized successfully.
Hyaluronan Fragments as Disease Drivers
Because large, intact hyaluronan is protective while fragments are inflammatory, diseases that generate a lot of fragments tend to involve chronic, low-grade inflammation. This pattern appears across a surprising range of conditions.
In obesity, small hyaluronan fragments (in the 15–40 kDa range) circulate at higher levels and activate immune cells. These tiny fragments trigger the production of inflammatory cytokines and activate a key inflammatory pathway, contributing to the persistent low-grade inflammation that makes obesity a risk factor for so many other diseases.
In the lungs, hyaluronan fragments accumulate after injury and signal through toll-like receptors on immune cells, driving macrophage influx and promoting the progression from acute injury toward fibrosis. The fragments trigger a distinct gene expression profile compared to bacterial signals, meaning the body’s response to its own degraded hyaluronan is immunologically unique.
The fragment story in cancer is more nuanced. Both intact hyaluronan and its fragments can interact with tumor cells, but the fragments appear particularly effective at promoting invasive behavior. In digestive tract cancers, these interactions activate downstream pathways that encourage cell proliferation, migration, the formation of new blood and lymph vessels feeding the tumor, and even stem-cell-like properties that make the cancer harder to treat.
The Naked Mole-Rat Connection
One of the most attention-grabbing findings in hyaluronan biology came from studies of naked mole-rats, the longest-lived rodents known, which are also remarkably resistant to cancer. Researchers discovered that naked mole-rat cells produce an unusually high-molecular-weight form of hyaluronan, and this molecule directly contributes to their cancer resistance. When scientists degraded the hyaluronan in naked mole-rat cells using an enzyme, or blocked its main receptor CD44 with an antibody, those cells became susceptible to cancer-like transformation for the first time.
The story got more interesting when researchers introduced the naked mole-rat version of the gene responsible for this high-molecular-weight hyaluronan (HAS2) into ordinary mice. The engineered mice showed improved healthspan, suggesting that abundant high-molecular-weight hyaluronan contributes not only to cancer resistance but potentially to the animal’s exceptional longevity. Whether this can be translated into anything useful for humans remains an open question, but it has intensified interest in understanding exactly how hyaluronan size affects aging and disease.
Clinical Uses in Joints and Eyes
The most established medical application of hyaluronan is injection directly into arthritic joints, a treatment called viscosupplementation. The idea is straightforward: osteoarthritis degrades the hyaluronan in joint fluid, so injecting fresh, high-molecular-weight hyaluronan should restore some of its lubricating and shock-absorbing properties. Systematic reviews have found that these injections provide pain relief and functional improvement for up to six months.
The effects go beyond simple lubrication, though. Injected hyaluronan can reduce nerve sensitivity associated with osteoarthritis pain, stimulate cartilage cells to produce their own hyaluronan and structural proteins, and reduce the production of inflammatory molecules and tissue-degrading enzymes. Many of these effects depend on the molecular weight of the injected product, with higher-weight preparations generally performing differently from lower-weight ones.
In ophthalmology, hyaluronan-based eye drops are widely used to treat dry eye, particularly after cataract surgery. A meta-analysis found that sodium hyaluronate, added to standard anti-inflammatory treatment, significantly improved dry eye symptom scores and clinical measures in post-surgical patients. Combination formulations pairing hyaluronan with other protective molecules like trehalose have shown particular promise for reducing both the signs and symptoms of dry eye in this setting.
Dermal Fillers and Cosmetic Uses
Hyaluronan-based fillers dominate the cosmetic injection market, and for good reason: hyaluronan is naturally present in skin, is gradually broken down by the body’s own enzymes, and can be dissolved with an injection of hyaluronidase if something goes wrong. To make it last longer than the few days that unmodified hyaluronan survives in tissue, manufacturers chemically crosslink the chains. The industry standard crosslinker, a molecule called BDDE, has a clinical track record spanning over two decades.
The crosslinked gel resists enzymatic breakdown long enough to provide volume for months, but is eventually metabolized through the same pathways that handle your body’s own hyaluronan. Different products vary in how tightly they are crosslinked, how concentrated the hyaluronan is, and how large the particles are, which is why different fillers are suited to different areas of the face. The chin, lips, and under-eye hollow all call for different mechanical properties, and the engineering of these products has become quite sophisticated.
Oral Supplements and Skin Hydration
The question of whether eating or drinking hyaluronan does anything useful is one of the most commercially loaded questions in the field. A randomized, double-blind trial found that oral hyaluronan supplementation significantly improved skin hydration within two to eight weeks in both younger and older participants, with skin tone improvements appearing after four to eight weeks and increased epidermal thickness after twelve weeks. These results are encouraging but should be weighed against the fact that the supplement industry has a strong financial interest in positive findings, and the mechanisms by which ingested hyaluronan reaches the skin in any meaningful concentration are still debated.
The challenge is biological plausibility. Hyaluronan is a large molecule, and the digestive system breaks most large molecules into smaller units before absorbing them. Whether those smaller fragments retain any useful biological activity by the time they reach skin tissue is a question that current evidence can gesture at but not definitively answer.
Drug Delivery and Targeting Tumors
Hyaluronan’s natural affinity for the CD44 receptor has made it attractive as a targeting vehicle for cancer drugs. Many tumors overexpress CD44 on their surfaces, so coating a drug-carrying nanoparticle with hyaluronan can steer it toward tumor cells. In one approach, researchers built hyaluronan-based micelles (tiny drug-carrying spheres) that released their cargo specifically inside cells. These micelles showed dramatically enhanced accumulation in tumors compared to the free drug alone, with fluorescent signal in tumors measured at four to nearly seven times stronger than the free dye within six hours of injection in animal studies.
This is still an area of active research rather than routine clinical practice, but hyaluronan-based drug delivery systems have entered clinical trials for several cancer types. The appeal is that you are essentially using the body’s own molecule as a Trojan horse, exploiting cancer’s hijacking of normal cell-surface receptors to deliver treatment precisely where it is needed.
When Bacteria Wear Hyaluronan as a Disguise
Some pathogens have evolved to exploit hyaluronan’s familiarity to the immune system. Group A Streptococcus, the bacterium responsible for strep throat and necrotizing fasciitis, wraps itself in a capsule made of hyaluronan that is chemically identical to the host’s own. Because the immune system recognizes this molecule as “self,” the capsule helps the bacterium evade detection and resist being engulfed by immune cells like neutrophils.
This molecular mimicry is a genuine stealth strategy. Experiments have shown that streptococci with intact hyaluronan capsules are significantly better at surviving in nasal and skin tissue than strains lacking the capsule, precisely because the capsule shields them from neutrophil-mediated killing. The host is not entirely defenseless, however. Breaking down the bacterial hyaluronan capsule actually contributes to immune defense, because the resulting fragments can themselves trigger inflammatory signaling, alerting the immune system that something is wrong.
Evolutionary Origins
Given how central hyaluronan is to vertebrate biology, it is surprising how recently it appeared in evolutionary terms. The sea squirt, a simple marine animal in the same broad group as vertebrates, shows no evidence of hyaluronan-making genes in its genome. The earliest organism known to produce hyaluronan is amphioxus, a small, fish-like creature that branched off roughly 400 million years ago. By the time bony fish evolved, the hyaluronan toolkit was well established, with zebrafish possessing multiple hyaluronan synthase genes and several hyaluronidase genes.
This means hyaluronan is an innovation specific to vertebrates, not something inherited from ancient single-celled ancestors. Its emergence roughly coincided with the evolution of complex connective tissues, internal skeletons, and immune systems that distinguish vertebrates from their invertebrate relatives. The fact that a molecule central to joint lubrication, skin hydration, immune regulation, and embryonic development appeared relatively late in evolutionary history suggests it may have been one of the enabling innovations that made vertebrate body plans possible in the first place.